Klivira
Request demo

Streamlining UnitedHealthcare Infusion Therapy Prior Authorization

Successfully managing UnitedHealthcare Infusion Therapy prior authorization is critical for revenue cycle integrity. Klivira provides the automation and intelligence needed to navigate UHC's specific requirements.

Infusion therapy, encompassing both medical and pharmacy benefit specialty drugs, represents a high-cost service category under intense payer scrutiny. For revenue cycle directors and prior authorization coordinators, understanding UnitedHealthcare's specific channels, medical policies, and site-of-service criteria is essential to minimize denials and accelerate patient access to care.

Understanding Infusion Therapy PA with UnitedHealthcare

Infusion therapy involves administering specialty drugs via intravenous or subcutaneous routes, often identified by J-codes or other HCPCS codes for the drug, and CPT codes for administration (e.g., 96365, 96374, 96413, 96415). UnitedHealthcare's prior authorization process for these services focuses heavily on medical necessity, appropriate site of service, and comprehensive clinical documentation. The split between medical and pharmacy benefit for specialty injectables and infusions is therapeutic-class specific, necessitating careful verification.

UnitedHealthcare's Prior Authorization Channels for Infusion Therapy

For medical benefit infusion services, UnitedHealthcare directs the majority of prior authorization submissions through the UnitedHealthcare Provider Portal at uhcprovider.com. This portal supports member lookup, procedure-specific PA initiation, and document uploads. For high-volume submitters, X12 278 transactions are accepted via clearinghouses for impacted procedures. Pharmacy benefit specialty infusions, managed by OptumRx, typically route through OptumRx's provider PA system or through ePA partners like CoverMyMeds and Surescripts for prescriber-initiated workflows.

Medical Policy and Criteria for Infusion Services

UnitedHealthcare publishes its medical necessity criteria and coverage rules through its public Medical Policy Library. These policies often reference external criteria sources such as MCG (formerly Milliman Care Guidelines) or the NCCN Compendium for oncology-related infusions. For infusion therapy, policies frequently detail clinical indications, required preceding therapies (step therapy), and specific site-of-service requirements. Accessing the correct policy number and effective date is crucial for accurate submission.

Key Considerations for Infusion Site-of-Service

A major dimension of UnitedHealthcare's prior authorization for infusion therapy is the site-of-service review. Policies often prefer lower-cost settings such as home infusion or freestanding outpatient infusion centers over hospital outpatient departments (HOPD) when clinically appropriate. Providers must document the medical necessity for a specific site, especially for HOPD settings. This review is distinct from the medical/pharmacy benefit split, which also dictates the PA process.

Navigating Denials and Appeals for Infusion Therapy

Common denial reasons for UnitedHealthcare Infusion Therapy prior authorizations include insufficient clinical documentation, lack of medical necessity, site-of-service mismatch, or failure to meet step therapy requirements. Denials are typically returned via X12 277/835 transactions or portal status updates. Providers can pursue appeal pathways, which differ by line of business (Commercial, Medicare Advantage, Community Plan), with peer-to-peer reviews available for clinical denials.

Electronic Prior Authorization (ePA) for Infusion Therapy

UnitedHealthcare is a public participant in the HL7 Da Vinci Project, exploring solutions like Da Vinci PAS for electronic prior authorization. For pharmacy benefit infusions, ePA is available through partners like CoverMyMeds and Surescripts. It's important to note that UnitedHealthcare's Medicare Advantage and Medicaid managed care lines are impacted by CMS-0057-F, which mandates phased compliance for electronic prior authorization APIs and decision timeframes, though this does not directly apply to commercial lines.

Frequently asked questions

How do I submit a medical benefit prior authorization for infusion therapy to UnitedHealthcare?

For medical benefit infusions, the primary submission channel is the UnitedHealthcare Provider Portal at uhcprovider.com. You can initiate a new prior authorization request, look up members, and upload necessary clinical documentation. Alternatively, X12 278 transactions are accepted via clearinghouses for applicable procedures.

What are UnitedHealthcare's site-of-service requirements for infusion therapy?

UnitedHealthcare frequently employs site-of-service review for infusion therapy, often preferring lower-cost settings like home infusion or freestanding infusion centers over hospital outpatient departments. Clinical documentation must support the medical necessity for the chosen site, especially if it's a higher-cost setting. Review the specific medical policy for the drug and administration for detailed criteria.

How can I access UnitedHealthcare's medical policies for infusion drugs?

UnitedHealthcare publishes its medical necessity criteria and coverage rules in its public Medical Policy Library. This resource is searchable by topic and includes both UnitedHealthcare-developed policies and references to external criteria like MCG or NCCN. Always reference the specific policy number and effective date relevant to your submission.

What are common reasons for infusion therapy prior authorization denials from UnitedHealthcare?

Common denial categories include insufficient clinical documentation, lack of demonstrated medical necessity, failure to meet step therapy requirements, or a mismatch with UnitedHealthcare's site-of-service criteria. Denials may also occur if the drug is considered non-formulary under the pharmacy benefit or for off-label use without compendium support.

Does UnitedHealthcare support electronic prior authorization (ePA) for infusion services?

For pharmacy benefit infusions managed by OptumRx, ePA is supported through industry partners like CoverMyMeds and Surescripts. For medical benefit infusions, UnitedHealthcare participates in the HL7 Da Vinci Project to advance electronic PA capabilities. Medicare Advantage and Medicaid managed care lines will also be impacted by future CMS-0057-F mandates for electronic PA.

How does OptumRx factor into infusion therapy prior authorization with UnitedHealthcare?

OptumRx, as the UnitedHealth Group-owned PBM, manages prior authorizations for infusion therapies covered under the pharmacy benefit. This often includes specialty drugs that are self-administered or delivered via mail-order. It's crucial to verify whether a specific infusion drug falls under the medical or pharmacy benefit, as this dictates the PA submission pathway.

Related coverage

Other infusion-therapy prior authorization by payer

Other infusion-therapy prior authorization by specialty

Ready to automate prior auth for this procedure?

See how Klivira automates prior authorizations for your team.

Request a demo